Events
Retrophin, Inc. joins the National Organization for Rare Disorders, the European Organisation for Rare Diseases, and others worldwide to recognize Rare Disease Day® 2019.
Medigene AG announced that researchers of the Company will present a poster at the 2019 American Association for Cancer Research Annual Meeting.
Shares of Bristol-Myers Squibb took a hit Wednesday after two large stakeholders in the company objected to the pending acquisition of Celgene. Wellington and Starboard Value have both publicly voiced opposition to the deal.
Contributing Further to Patients With Mycetoma, a Neglected Tropical Disease
Ethisphere announced its 13th Annual World’s Most Ethical Companies list and one biopharmaceutical company made it—Eli Lilly & Co.
Amicus Therapeutics, headquartered in Cranbury, New Jersey, announced it is launching a Global Research and Gene Therapy Center of Excellence in Philadelphia.
An updated webcast of the Soligenix Corporate Presentation, given by Dr. Christopher J. Schaber, President and CEO, is available on the Company website. To listen and view the presentation, please visit www.soligenix.com.
Planegg Medigene AG announced its participation at the following upcoming scientific conferences
MorphoSys AG will present at the following conference.
PRESS RELEASES